The simultaneous open-market sales by both the CEO and CLO on the same day, without a disclosed 10b5-1 plan, is an unusual pattern that warrants monitoring. Watch for any upcoming 8-K filings, earnings pre-announcements, or material developments in the next 30 days that could explain the insider urgency.
Price Chart
Executive Summary
CEO Mark Locke and CLO Thomas Russell sold a combined $653K in open-market shares on September 17, 2026, at ~$6.52/share. The sales represent ~0.2% of GENI's ~$326M market cap, a modest but notable cluster of insider selling by the two most senior executives on the same day.
Key Financial Metrics
Key Facts
- CEO Mark Locke sold 50,000 shares for $327K on 2026-09-17
- CLO Thomas Russell sold 50,000 shares for $326K on 2026-09-17
- Total cluster value: $653K, representing ~0.2% of market cap
- Both sales were open-market (code S) with no 10b5-1 plan indicated
- Sales occurred on the same day, suggesting coordinated or event-driven selling
Financial Impact
Insider selling of $653K, ~0.2% of market cap
Risk Factors
- Insider selling may signal management's concern about near-term business performance or valuation
- No disclosed 10b5-1 plan raises the possibility of informed selling
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GENI-1789798021612 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 17, 2026 5w ago | Insider Cluster | $5.64 $6.35 | ▼ −12.59% | ▼ −12.38% | $6.52 (−15.60%) |
Aug 6, 2026 11w ago | 6-K | $7.83 $7.63 | ▼ −2.55% | ▼ −3.15% | $6.52 (−16.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers